About Recursion Pharmaceuticals, Inc. 
Recursion Pharmaceuticals, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 47 Schemes (25.57%)
Foreign Institutions
Held by 156 Foreign Institutions (26.75%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
6 Million
(Quarterly Results - Mar 2026)
Net Profit:
-118 Million
Pharmaceuticals & Biotechnology
USD 1,553 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.63
-57.01%
1.37






